Log in

NASDAQ:MDRXAllscripts Healthcare Solutions Competitors & Alternatives

$6.59
-0.01 (-0.15 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.50
Now: $6.59
$6.79
50-Day Range
$5.85
MA: $6.65
$7.58
52-Week Range
$4.56
Now: $6.59
$11.82
Volume849,846 shs
Average Volume2.40 million shs
Market Capitalization$1.07 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.98

Competitors

Allscripts Healthcare Solutions (NASDAQ:MDRX) Vs. SAIC, PSN, VRNT, NTCT, SGMS, and OSPN

Should you be buying MDRX stock or one of its competitors? Companies in the industry of "computer integrated systems design" are considered alternatives and competitors to Allscripts Healthcare Solutions, including Science Applications International (SAIC), Parsons (PSN), Verint Systems (VRNT), NetScout Systems (NTCT), Scientific Games (SGMS), and Onespan (OSPN).

Science Applications International (NYSE:SAIC) and Allscripts Healthcare Solutions (NASDAQ:MDRX) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability.

Insider & Institutional Ownership

75.2% of Science Applications International shares are owned by institutional investors. 0.9% of Science Applications International shares are owned by insiders. Comparatively, 1.4% of Allscripts Healthcare Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Science Applications International and Allscripts Healthcare Solutions' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Science Applications International3.17%25.32%7.04%
Allscripts Healthcare Solutions-11.10%4.98%1.97%

Analyst Recommendations

This is a summary of current ratings and target prices for Science Applications International and Allscripts Healthcare Solutions, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Science Applications International001103.00
Allscripts Healthcare Solutions27402.15

Science Applications International currently has a consensus price target of $100.70, suggesting a potential upside of 46.01%. Allscripts Healthcare Solutions has a consensus price target of $8.50, suggesting a potential upside of 28.98%. Given Science Applications International's stronger consensus rating and higher possible upside, analysts plainly believe Science Applications International is more favorable than Allscripts Healthcare Solutions.

Risk & Volatility

Science Applications International has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500. Comparatively, Allscripts Healthcare Solutions has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500.

Valuation & Earnings

This table compares Science Applications International and Allscripts Healthcare Solutions' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Science Applications International$6.38 billion0.63$226 million$5.6612.19
Allscripts Healthcare Solutions$1.77 billion0.60$-182,180,000.00$0.4714.02

Science Applications International has higher revenue and earnings than Allscripts Healthcare Solutions. Science Applications International is trading at a lower price-to-earnings ratio than Allscripts Healthcare Solutions, indicating that it is currently the more affordable of the two stocks.

Summary

Science Applications International beats Allscripts Healthcare Solutions on 13 of the 14 factors compared between the two stocks.

Parsons (NYSE:PSN) and Allscripts Healthcare Solutions (NASDAQ:MDRX) are both business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

Insider and Institutional Ownership

99.5% of Parsons shares are owned by institutional investors. 0.2% of Parsons shares are owned by insiders. Comparatively, 1.4% of Allscripts Healthcare Solutions shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Parsons and Allscripts Healthcare Solutions' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Parsons3.08%53.05%3.93%
Allscripts Healthcare Solutions-11.10%4.98%1.97%

Risk & Volatility

Parsons has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500. Comparatively, Allscripts Healthcare Solutions has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Parsons and Allscripts Healthcare Solutions, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Parsons11502.57
Allscripts Healthcare Solutions27402.15

Parsons currently has a consensus price target of $41.40, suggesting a potential upside of 25.11%. Allscripts Healthcare Solutions has a consensus price target of $8.50, suggesting a potential upside of 28.98%. Given Allscripts Healthcare Solutions' higher possible upside, analysts plainly believe Allscripts Healthcare Solutions is more favorable than Parsons.

Earnings and Valuation

This table compares Parsons and Allscripts Healthcare Solutions' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Parsons$3.95 billion0.84$120.53 million$1.4622.66
Allscripts Healthcare Solutions$1.77 billion0.60$-182,180,000.00$0.4714.02

Parsons has higher revenue and earnings than Allscripts Healthcare Solutions. Allscripts Healthcare Solutions is trading at a lower price-to-earnings ratio than Parsons, indicating that it is currently the more affordable of the two stocks.

Summary

Parsons beats Allscripts Healthcare Solutions on 12 of the 14 factors compared between the two stocks.

Verint Systems (NASDAQ:VRNT) and Allscripts Healthcare Solutions (NASDAQ:MDRX) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

Profitability

This table compares Verint Systems and Allscripts Healthcare Solutions' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Verint Systems1.65%12.14%5.11%
Allscripts Healthcare Solutions-11.10%4.98%1.97%

Earnings and Valuation

This table compares Verint Systems and Allscripts Healthcare Solutions' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Verint Systems$1.30 billion2.08$28.68 million$2.6216.05
Allscripts Healthcare Solutions$1.77 billion0.60$-182,180,000.00$0.4714.02

Verint Systems has higher earnings, but lower revenue than Allscripts Healthcare Solutions. Allscripts Healthcare Solutions is trading at a lower price-to-earnings ratio than Verint Systems, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

90.9% of Verint Systems shares are owned by institutional investors. 1.7% of Verint Systems shares are owned by insiders. Comparatively, 1.4% of Allscripts Healthcare Solutions shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk & Volatility

Verint Systems has a beta of 0.95, suggesting that its share price is 5% less volatile than the S&P 500. Comparatively, Allscripts Healthcare Solutions has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Verint Systems and Allscripts Healthcare Solutions, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Verint Systems00703.00
Allscripts Healthcare Solutions27402.15

Verint Systems currently has a consensus price target of $59.25, suggesting a potential upside of 40.94%. Allscripts Healthcare Solutions has a consensus price target of $8.50, suggesting a potential upside of 28.98%. Given Verint Systems' stronger consensus rating and higher possible upside, equities research analysts plainly believe Verint Systems is more favorable than Allscripts Healthcare Solutions.

Summary

Verint Systems beats Allscripts Healthcare Solutions on 12 of the 14 factors compared between the two stocks.

Allscripts Healthcare Solutions (NASDAQ:MDRX) and NetScout Systems (NASDAQ:NTCT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, dividends, analyst recommendations and risk.

Profitability

This table compares Allscripts Healthcare Solutions and NetScout Systems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Allscripts Healthcare Solutions-11.10%4.98%1.97%
NetScout Systems-0.31%3.83%2.40%

Valuation & Earnings

This table compares Allscripts Healthcare Solutions and NetScout Systems' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allscripts Healthcare Solutions$1.77 billion0.60$-182,180,000.00$0.4714.02
NetScout Systems$891.82 million2.10$-2,750,000.00$1.0025.39

NetScout Systems has lower revenue, but higher earnings than Allscripts Healthcare Solutions. Allscripts Healthcare Solutions is trading at a lower price-to-earnings ratio than NetScout Systems, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

96.2% of NetScout Systems shares are owned by institutional investors. 1.4% of Allscripts Healthcare Solutions shares are owned by company insiders. Comparatively, 4.1% of NetScout Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

Allscripts Healthcare Solutions has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, NetScout Systems has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Allscripts Healthcare Solutions and NetScout Systems, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Allscripts Healthcare Solutions27402.15
NetScout Systems11102.00

Allscripts Healthcare Solutions presently has a consensus target price of $8.50, suggesting a potential upside of 28.98%. NetScout Systems has a consensus target price of $25.00, suggesting a potential downside of 1.54%. Given Allscripts Healthcare Solutions' stronger consensus rating and higher probable upside, analysts clearly believe Allscripts Healthcare Solutions is more favorable than NetScout Systems.

Summary

NetScout Systems beats Allscripts Healthcare Solutions on 8 of the 14 factors compared between the two stocks.

Allscripts Healthcare Solutions (NASDAQ:MDRX) and Scientific Games (NASDAQ:SGMS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, dividends, analyst recommendations and risk.

Profitability

This table compares Allscripts Healthcare Solutions and Scientific Games' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Allscripts Healthcare Solutions-11.10%4.98%1.97%
Scientific Games-8.06%-0.53%-0.06%

Valuation & Earnings

This table compares Allscripts Healthcare Solutions and Scientific Games' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allscripts Healthcare Solutions$1.77 billion0.60$-182,180,000.00$0.4714.02
Scientific Games$3.40 billion0.46$-130,000,000.00$0.2371.33

Scientific Games has higher revenue and earnings than Allscripts Healthcare Solutions. Allscripts Healthcare Solutions is trading at a lower price-to-earnings ratio than Scientific Games, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

59.6% of Scientific Games shares are owned by institutional investors. 1.4% of Allscripts Healthcare Solutions shares are owned by company insiders. Comparatively, 40.3% of Scientific Games shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

Allscripts Healthcare Solutions has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, Scientific Games has a beta of 2.51, meaning that its stock price is 151% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Allscripts Healthcare Solutions and Scientific Games, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Allscripts Healthcare Solutions27402.15
Scientific Games03302.50

Allscripts Healthcare Solutions presently has a consensus target price of $8.50, suggesting a potential upside of 28.98%. Scientific Games has a consensus target price of $31.20, suggesting a potential upside of 90.19%. Given Scientific Games' stronger consensus rating and higher probable upside, analysts clearly believe Scientific Games is more favorable than Allscripts Healthcare Solutions.

Summary

Scientific Games beats Allscripts Healthcare Solutions on 8 of the 14 factors compared between the two stocks.

Onespan (NASDAQ:OSPN) and Allscripts Healthcare Solutions (NASDAQ:MDRX) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.

Insider & Institutional Ownership

68.9% of Onespan shares are held by institutional investors. 18.0% of Onespan shares are held by insiders. Comparatively, 1.4% of Allscripts Healthcare Solutions shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings for Onespan and Allscripts Healthcare Solutions, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Onespan02302.60
Allscripts Healthcare Solutions27402.15

Onespan presently has a consensus target price of $25.00, suggesting a potential downside of 7.99%. Allscripts Healthcare Solutions has a consensus target price of $8.50, suggesting a potential upside of 28.98%. Given Allscripts Healthcare Solutions' higher probable upside, analysts plainly believe Allscripts Healthcare Solutions is more favorable than Onespan.

Profitability

This table compares Onespan and Allscripts Healthcare Solutions' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Onespan5.53%10.91%7.58%
Allscripts Healthcare Solutions-11.10%4.98%1.97%

Earnings and Valuation

This table compares Onespan and Allscripts Healthcare Solutions' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Onespan$254.57 million4.30$8.79 million$0.5450.31
Allscripts Healthcare Solutions$1.77 billion0.60$-182,180,000.00$0.4714.02

Onespan has higher earnings, but lower revenue than Allscripts Healthcare Solutions. Allscripts Healthcare Solutions is trading at a lower price-to-earnings ratio than Onespan, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Onespan has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Allscripts Healthcare Solutions has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500.

Summary

Onespan beats Allscripts Healthcare Solutions on 11 of the 14 factors compared between the two stocks.

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Science Applications International logo
SAIC
Science Applications International
2.7$68.97-3.0%$4.13 billion$6.38 billion19.54Insider Buying
PSN
Parsons
1.5$33.09-3.7%$3.45 billion$3.95 billion25.85Analyst Upgrade
Verint Systems logo
VRNT
Verint Systems
1.6$42.04-3.4%$2.81 billion$1.30 billion135.61
NetScout Systems logo
NTCT
NetScout Systems
1.2$25.39-0.5%$1.87 billion$891.82 million-1,269.50
Scientific Games logo
SGMS
Scientific Games
1.6$16.41-4.3%$1.62 billion$3.40 billion-5.80
OSPN
Onespan
1.2$27.17-6.0%$1.15 billion$254.57 million73.43
Simulations Plus logo
SLP
Simulations Plus
1.9$62.46-0.0%$1.11 billion$33.97 million124.92Earnings Announcement
Dividend Announcement
Sykes Enterprises logo
SYKE
Sykes Enterprises
1.7$25.60-0.4%$1.04 billion$1.61 billion15.90
NXGN
Nextgen Healthcare
1.2$10.77-3.7%$718.50 million$540.24 million89.75
Unisys logo
UIS
Unisys
1.5$10.57-1.8%$677.56 million$2.95 billion0.65
Ebix logo
EBIX
Ebix
1.6$20.45-2.2%$610.51 million$580.61 million6.53Heavy News Reporting
Ribbon Communications logo
RBBN
Ribbon Communications
1.4$3.84-7.6%$597.90 million$563.11 million-3.28
Agilysys logo
AGYS
Agilysys
1.5$17.27-3.0%$408.55 million$160.76 million-11.75
TUFN
Tufin Software Technologies
1.4$9.73-3.5%$326.63 million$103.27 million-8.18
Digimarc logo
DMRC
Digimarc
1.4$14.05-4.8%$186.22 million$22.99 million-5.02Analyst Upgrade
Asure Software logo
ASUR
Asure Software
2.1$6.48-1.9%$102.03 million$73.15 million3.22
TEUM
Pareteum
0.7$0.63-3.3%$72.71 million$32.44 million-2.63
BRQS
Borqs Technologies
0.4$1.17-5.1%$39.59 million$128.42 million0.00
Streamline Health Solutions logo
STRM
Streamline Health Solutions
0.9$1.22-0.8%$38.12 million$20.74 million0.00
CSPI
CSP
1.0$7.79-1.9%$33.76 million$79.06 million-27.82
This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.